Showing 34,893 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Men who have sex with men (MSM)

Nigerian government must scale up fight against HIV

Editor's pick
Key Correspondents
24 February 2016
Human rights

HIV and TB link the Bronx and Tugela Ferry in a story of human rights and social justice

Editor's pick
Science Speaks
24 February 2016
Human rights

Russia Proposes Dedicated Health Facilities To Treat Homosexuality And Pedophilia

Editor's pick
Sexuality Policy Watch
24 February 2016
Starting treatment

Starting HIV treatment at first clinic visit improves outcomes in African study

News
24 February 2016
New & experimental HIV treatments

Gilead announces results from first study to evaluate switching to FTAF-based regimens from Truvada® (FTDF)-based regimens

Editor's pick
Gilead press release
24 February 2016
Epidemiology & behaviour

Major disparities persist in lifetime risk of HIV diagnosis in the US

News
24 February 2016
PrEP

Where Are the PrEP Interventions for People Who Inject Drugs?

Editor's pick
The Body
24 February 2016
HIV testing programmes & uptake

During pregnancy, offering HIV testing at home doubles the proportion of male partners who test

News
24 February 2016
Undetectable viral load & treatment as prevention

People with HIV considerably overestimate their chance of infecting someone

News
24 February 2016

Fevereiro de 2016

February 2016
PrEP science

Bone density recovers quickly after stopping PrEP

News
24 February 2016
The search for a cure

New molecular scissors cut out lingering HIV—maybe once and for all

Editor's pick
Ars Technica
24 February 2016
New & experimental HIV treatments

Dose-finding trials of antibody-based drugs for HIV prevention will start soon

News
24 February 2016
New & experimental HIV treatments

Long-acting injectable cabotegravir + rilpivirine works well as HIV maintenance therapy

News
23 February 2016
Cardiovascular disease

Early antiretroviral therapy has no impact on marker of early cardiovascular disease

News
23 February 2016
Neurological & cognitive problems

Women and African Americans with HIV have a higher risk of stroke

News
23 February 2016
Bone & joint problems

Tenofovir treatment raises the risk of broken bones

News
23 February 2016
PrEP

Israeli Health Ministry Approves Pre-exposure Prophylaxis for HIV

Editor's pick
Haaretz
23 February 2016
Improving HIV care

Dying from a treatable disease: HIV and the men we neglect

Editor's pick
The Conversation
23 February 2016
Pharmaceutical industry

Bristol-Myers Squibb completes previously announced sale of its HIV R&D portfolio to ViiV Healthcare

Editor's pick
Bristol-Myers Squibb press release
23 February 2016
Pharmaceutical industry

Study finds access to high-priced medicines may differ across EU

Editor's pick
Health Action International
23 February 2016
HIV prevention policy

£111m cuts will spark public health crisis in London, warns Sadiq Khan

Editor's pick
Evening Standard
23 February 2016
Finance & funding

The UK’s LGBT Charities Are Under Threat

Editor's pick
i-D
23 February 2016
People & personal stories

Charlie Sheen did more for HIV education than most UN events do. There's a lesson in that.

Editor's pick
Vox
22 February 2016